Home  |  Contact

UniProtKB/Swiss-Prot P11802: Variant p.Arg24Cys

Cyclin-dependent kinase 4
Gene: CDK4
Variant information

Variant position:  24
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Arginine (R) to Cysteine (C) at position 24 (R24C, p.Arg24Cys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and basic (R) to medium size and polar (C)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In CMM3; somatic and familial; generates a dominant oncogene resistant to inhibition by p16(INK4a).
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  24
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  303
The length of the canonical sequence.

Location on the sequence:   SRYEPVAEIGVGAYGTVYKA  R DPHSGHFVALKSVRVPNGGG
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         SRYEP------------------------------------------------VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG

Mouse                         TRYEP------------------------------------

Rat                           TRYEP------------------------------------

Pig                           SRYEP------------------------------------

Bovine                        SRYEP------------------------------------

Sheep                         SRYEP------------------------------------

Xenopus laevis                GQYEP------------------------------------

Caenorhabditis elegans        QRQKPSNFHFWTVIKKFSKKILKSFIIKFGNNGTIAVVFSI

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 2 – 303 Cyclin-dependent kinase 4
Domain 6 – 295 Protein kinase
Binding site 35 – 35 ATP
Alternative sequence 1 – 120 Missing. In isoform 2.
Beta strand 20 – 24


Literature citations

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.
Wolfel T.; Hauer M.; Schneider J.; Serrano M.; Wolfel C.; Klehmann-Hieb E.; De Plaen E.; Hankeln T.; Meyer Zum Bueschenfelde K.-H.; Beach D.;
Science 269:1281-1284(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1); VARIANT CMM3 CYS-24; CHARACTERIZATION OF VARIANT CYS-24;

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
Zuo L.; Weger J.; Yang Q.; Goldstein A.M.; Tucker M.A.; Walker G.J.; Hayward N.; Dracopoli N.C.;
Nat. Genet. 12:97-99(1996)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANT CMM3 CYS-24; CHARACTERIZATION OF VARIANT CYS-24;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.